Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 华东医药股份有限公司是一家医药生产及医药器械制造的企业.公司的主要产品主要为西药及中药药品、医药器械等.1997年1月17日,公司更名为杭州华东医药股份有限公司,公司从单纯的商业企业一举成为集医药产品生产和销售网络于一体的、工商紧密结合的医药生产企业.2010年,公司医药商业继续保持浙江省行业领先地位。 公司多年来深耕专科、慢病及特殊用药领域，在慢性肾病、免疫、内分泌、肿瘤、消化系统、心血管等治疗领域构筑了良好的品牌效应和雄厚的市场基础，市场占有率持续保持国内同类产品前列。同时公司在肿瘤、内分泌和自身免疫三大核心治疗领域均已有全球首创新药（first-in-class）上市，并形成了ADC、GLP-1、外用制剂三大特色产品矩阵，构筑差异化优势。 公司深耕糖尿病用药领域二十余年，在糖尿病临床主流治疗靶点形成了创新药和差异化仿制药产品管线全面布局，目前商业化及在研产品达到二十余款，积累了良好的品牌效应和雄厚的市场基础。公司现有及后续升级产品涵盖α-糖苷酶抑制剂、DPP-4抑制剂、SGLT-2抑制剂、GLP-1受体单靶点及长效多靶点激动剂、胰岛素及其类似物等多项临床主流靶点。围绕GLP-1靶点，公司已构筑了包括口服片剂、注射剂在内的长效及多靶点全球创新药和生物类似药相结合的全方位和差异化的产品管线。
Main Business 药品的研发、生产和销售
Legal Representative 吕梁
Top Executives
董事长：吕梁
董事：叶波,朱飞鹏,王旸,朱亮,亢伟,吕梁
独立董事：黄简,高向东,王如伟
Top 5 Shareholder
Shareholder name Nature Holding Date
中国远大集团有限责任公司流通A股41.67%31/03/2025
杭州华东医药集团有限公司流通A股16.42%31/03/2025
香港中央结算有限公司流通A股2.63%31/03/2025
中国证券金融股份有限公司流通A股1.26%31/03/2025
中国工商银行股份有限公司－中欧医疗健康混合型证券投资基金流通A股1.19%31/03/2025
Company Secretary 陈波
Solicitors 浙江天册律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0571-89903300
Fax No 0571-89903300
Website www.eastchinapharm.com
Email hz000963@126.com
Company Address
Register: 浙江省杭州市中山北路439号杭州医药大楼4、7楼
Office: 浙江省杭州市莫干山路866号
Listing Date 27/01/2000
Shares Capital
Shares Capital: 1,754,077,048
Total A Share: 1,754,077,048
Listed A Share: 1,751,941,228
Non-tradable A Share: 2,135,820
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 2.005
DPS(RMB)* ¥ 0.930
NBV Per Share(RMB)* ¥ 13.145
Market Capitalization(RMB) 67.923B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.